Market revenue in 2023 | USD 4,074.8 million |
Market revenue in 2030 | USD 5,732.9 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Liquid Delivery Device |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 44.02% in 2023. Horizon Databook has segmented the Latin America intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare spending of this region is reported to be around 7.6% of GDP, which is third in terms of healthcare spending after North America and Western Europe. Growing health awareness and increasing demand for technologically upgraded medical devices for long-term care are among some key factors expected to boost market growth.
These countries have vibrant research relations with China and Europe. Furthermore, pharmaceutical industries in countries such as Mexico and Brazil have been expanding with untapped market opportunities and investments by foreign countries to expand their regional presence. Increase in chronic diseases in the region has also contributed to a rise in the production of drugs and biologics.
Thus, these factors have been contributing to market growth in Latin American region. Initiatives such as eHealth initiative undertaken by the Pan American Health Organization and WHO in Latin America to improve healthcare infrastructure is likely to further support market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America intranasal drug and vaccine delivery market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account